One of the most common medication errors occurs when 2 drug names that look similar are confused. Human factors experts tell us that "confirmation bias" plays a role. Confirmation bias means that you are more likely to believe information that supports your view rather than information that does not. Another way of putting it is that you are more likely to see what you are most familiar with, not what is really there.
For example, a pharmacist sent a report to the Institute for Safe Medication Practices (ISMP) with a good example of confirmation bias. Several prescriptions written for "Sinequan" (doxepin) have been misread in his pharmacy as "Singulair" (montelukast). In this pharmacy, staff rarely saw prescriptions written using the brand name Sinequan. Since the drug has long been available generically, "doxepin" has been the name most often used by prescribers. On the other hand, prescriptions for "Singulair" are seen commonly. Prescribers rarely use "montelukast" when prescribing. When handwritten, the 2 drug names (Sinequan and Singulair) can look similar.
Confirmation bias led staff to see the name that was most familiar to themSingulairrather than what was actually being communicatedSinequan. The fact that these drugs are both given orally, often in the same 10-mg strength at a similar dosing interval, adds to the potential for confusion. Since pharmacists preparing a medication may not be able to recognize that they have selected the wrong drug, blaming them for the error is fruitless. Instead, focus on ways of improving the system. Place reminders on containers or in your computer system to alert staff about commonly confused look-alike drug names. Improve checking accuracy by having another pharmacy staff member view completed prescriptions. During counseling, verify the purpose of the medication with the patient. Encourage prescribers to include the purpose of each medication on prescriptions.
Mix-ups Involving Zetia
ISMP received a report from a patient who had been taking Lipitor (atorvastatin) to treat hypercholesterolemia. Although her cholesterol levels were under control, her physician changed her therapy to one of the newer agents, Zetia (ezetimibe) 10 mg daily, and phoned the prescription in to the patient's pharmacy. The pharmacist transcribed the telephone order correctly, but another pharmacist misread the transcription and dispensed the antihypertensive Zestril (lisinopril) 10 mg. The patient obtained 3 refills, each time receiving the wrong medication. Meanwhile, her blood cholesterol level increased.
ISMP has also heard about a mix-up between Zetia and the beta-blocker Zebeta (bisoprolol fumarate). Zetia 10 mg was prescribed, but Zebeta 10 mg was dispensed to the patient. At the time, the pharmacist was unfamiliar with Zetia. Consequently, the physician's handwritten prescription appeared to be the more familiar drug Zebeta. Fortunately, the error was discovered after the patient took only a few doses. The patient experienced hypotension, but no permanent harm resulted. In yet another report, an order for Zetia was misinterpreted as Bextra (valdecoxib).
In each of these cases, similarities in the dose, route, and frequency contributed to the errors. In addition, several letters are the same in each drug name. When combined with poor handwriting, these similarities can lead to mix-ups. Encourage patients to check their medication bottles and read patient information leaflets before taking a medication.
Dr. Kelly is the editor of ISMP Medication Safety Alert! Community/Ambulatory Care Edition.
Subscribe to Newsletter
Pharmacy Times and the Institute for Safe Medication Practices (ISMP) would like to make community pharmacy practitioners aware of a publication that is available.
The ISMP Medication Safety Alert! Community/Ambulatory Care Edition is a monthly compilation of medication-related incidents, error-prevention recommendations, news, and editorial content designed to inform and alert community pharmacy practitioners to potentially hazardous situations that may affect patient safety. Individual subscription prices are $45 per year for 12 monthly issues. Discounts are available for organizations with multiple pharmacy sites. This newsletter is delivered electronically. For more information, contact ISMP at 215-947-7797, or send an e-mail message to firstname.lastname@example.org.
Report Medication Errors
The reports described here were received through the USP Medication Errors Reporting Program, which is presented in cooperation with the Institute for Safe Medication Practices (ISMP). ISMP is a nonprofit organization whose mission is to understand the causes of medication errors and to provide time-critical error-reduction strategies to the health care community, policy makers, and the public. Throughout this series, the underlying system causes of medication errors will be presented to help readers identify system changes that can strengthen the safety of their operation.
If you have encountered medication errors and would like to report them, you may call ISMP at 800-324-5723 (800-FAILSAFE) or USP at 800-233-7767 (800-23-ERROR). ISMP's Web address is www.ismp.org.
The Oncology Care Pharmacist in Health-System Pharmacy
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.
News from the year's biggest meetings
Clinical features with downloadable PDFs